Home/Scholar Rock/Ted Myles

TM

Ted Myles

Chief Financial Officer

Roles

Chief Financial OfficeratScholar Rock

Chief Financial Officer and Head of Business OperationsatScholar Rock Holding

Therapeutic Areas

Neuromuscular Cardiometabolic Oncology Fibrosis Hematology

Scholar Rock Pipeline

Drug	Indication	Phase
Apitegromab (SRK-015)	Spinal Muscular Atrophy (Types 2 & 3)	Phase 3
SRK-181	Solid Tumors (Immuno-Oncology)	Phase 1
SRK-439	Obesity / Muscle Wasting	Preclinical

Leadership Team at Scholar Rock

President and Chief Executive Officer

Chairman of the Board

Chief Medical Officer

Nagesh Mahanthappa

Interim Chief Scientific Officer

Senior Director, Talent Acquisition

View full Scholar Rock profile